Netherlands· NL-72f277c8018e

Olanzapine Viatris 2,5 mg, filmomhulde tabletten

A olanzapine product containing olanzapine, registered in Netherlands by Viatris Limited. The same ATC class is registered in 18 of our 19 countries.

ATC N05AH03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about olanzapineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Olanzapine is registered in 18 of 19 countries.

Countries holding a registration under ATC N05AH03 (olanzapine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
11 of them publish a price we can compare per daily dose

Search olanzapine products by name

Olanzapine · ATC N05AH03

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of olanzapine costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.17 in United States to $3.34 in Switzerland — a ×19 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Olanzapine · price per daily dose (10 mg)

USD · FX 28 Sept 2026

CH Switzerland$3.34
IT Italy$1.59
FR France$0.63
US United States$0.17 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: OLANZAPINE
Manufacturer: Viatris Limited
Country: Netherlands (NL)
ATC code: N05AH03
ATC class: Olanzapine
Defined daily dose: 10 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/08/475

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

481 interactions on record for olanzapine.

Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check olanzapine against other medicines How interaction checks work

Olanzapine · interactions on record

481 records

14 severe
292 moderate
3 minor
137 info

Most severe, free to view

MetoclopramideA03FA01severe
Potassium chlorideA12BA01severe
Potassium citrateA12BA02severe
Potassium chlorideB05XA01severe

35 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Olanzapine in 18 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olanzapine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Aedon, Olanzapin +pharma
Belgium · Olanzapine, Olanzapine Ab
Bulgaria · Oлфрекс, Еголанза
Cyprus · Bloonis, Lapozan
Czechia · Egolanza, Nykob
Germany · Olanzapin 1 A Pharma, Olanzapin Abz
Denmark · Farpenta, Kynapine Odt
Estonia · Farpenta, Olanzapin Actavis
Spain · Arenbil, Arenbil Flas
Finland · Olanzapin Orion, Olanzapin Ratiopharm
France · Olanzapine Accord, Olanzapine Arrow
United Kingdom (Northern Ireland) · Olanzapine Accord, Olanzapine Bristol Laboratories
Greece · Bloonis, Caprilon Od
Croatia · Olandix, Olanzalux
Hungary · Egolanza, Olpinat
Ireland · Olanzapine Accord, Olanzapine Accord Healthcare Ireland
Iceland · Olanzapin Actavis, Olanzapine Teva
Italy · Farpenta, Lazapir
Liechtenstein · Olanzapine Teva, Olanzapine Viatris
Lithuania · Olanzapin Actavis, Olanzapine Accord
Luxembourg · Olanzapine Eg, Olanzapine Instant Eg
Latvia · Olanzapine Accord
Malta · Olancer, Olanzapine Aurobindo
Norway · Olanzapine Accord, Olanzapine Teva
Poland · Egolanza, Olanzapina Viatris
Portugal · Olanzapina Alter, Olanzapina Aurobindo
Romania · Olanzapină Arena, Olanzapina Aurobindo
Sweden · Olanzapin Actavis, Olanzapin Sandoz
Slovenia · Zolrix
Slovakia · Olanzapin Actavis, Olanzapin Viatris

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d7f5571a-c58f-4a98-8446-087f9f7b8afa
GET /v1/drugs/d7f5571a-c58f-4a98-8446-087f9f7b8afa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/olanzapine-viatris-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Olanzapine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp101821",
  "excipients": [
    "CROSPOVIDON (E 1202)",
    "LACTOSE 1-WATER",
    "LECITHINE, SOYA (E 322)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "POLYVINYLALCOHOL (E 1203)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "XANTHAANGOM (E 415)"
  ],
  "substances": [
    "OLANZAPINE"
  ],
  "leaflet_url": null,
  "authorised_at": "2008/10/07",
  "procedure_number": "EMEA/H/C/000961",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/08/475",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about olanzapine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console